Skip to main content
. 2019 Sep 4;8(2):173–182. doi: 10.12997/jla.2019.8.2.173

Fig. 2. Primary prevention: the role of ASCVD risk enhancer.

Fig. 2

ASCVD, atherosclerotic cardiovascular disease; apoB, apolipoprotein B; CAC, coronary artery calcium; HIV, human immunodeficiency virus; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein (a); CHD, coronary heart disease.